Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32 (Dealroom.co)
Faro’s new round is aimed at building AI into clinical development workflows.
The Series B totals $37.3 million, with Merck Global Health Innovation Fund and S32 co-leading. Dealroom says Faro develops data models and AI tools meant to speed up clinical trials. Linked coverage frames the raise around scaling agentic AI across clinical development. Techmeme's note
The Series B totals $37.3 million, with Merck Global Health Innovation Fund and S32 co-leading. Dealroom says Faro develops data models and AI tools meant to speed up clinical trials. Linked coverage frames the raise around scaling agentic AI across clinical development. Techmeme's note
score 6